Focused Alpha’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Focused Alpha's DGX Position: Q3 2026 in Review
Focused Alpha increased its Quest Diagnostics (DGX) stake by 1.7% in Q3 2026, buying an estimated $11.6K and bringing the position to 3,044 shares worth $710K. The position accounts for 0.18% of the portfolio, ranked #108.
Focused Alpha first reported a position in DGX in Q4 2025 and has held it in 4 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Focused Alpha held 3,044 shares of Quest Diagnostics worth $710K as of Q3 2026.
- Focused Alpha bought 50 Quest Diagnostics shares in Q3 2026, an estimated $11.6K.
- Quest Diagnostics made up 0.18% of Focused Alpha's portfolio in Q3 2026, its #108 holding.
- Focused Alpha first reported a position in Quest Diagnostics in Q4 2025 and has held it in 4 quarters since.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.